Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yan Pan

1PUBLICATIONS

8CO-AUTHORS

Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 08, 2023

Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving atezolizumab plus bevacizumab: a secondary analysis of IMbrave150 study.

Linbin Lu, Peichan Zheng, Yan Pan

Pageof 1

Frequent Collaborators

1 joint publications

Linbin Lu

1 joint publications

Peichan Zheng

1 joint publications

Shanshan Huang

1 joint publications

Erqian Shao

1 joint publications

Yayin Chen

1 joint publications

Wangting Guo

1 joint publications

Zhixian Wu

1 joint publications

Xiong Chen

Frequent Collaborators

1 joint publications

Linbin Lu

1 joint publications

Peichan Zheng

1 joint publications

Shanshan Huang

1 joint publications

Erqian Shao

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos